x

Bellerophon Therapeutics, Inc. (OTC:BLPH)

Health Care/Life Sciences • Pharmaceuticals
CIK 1600132
Company

Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.

Address
184 Liberty Corner Road
Suite 302
Warren, New Jersey 07059
Employees
18
Stock Info
Close
$0.0515
Day Range
0.0515 - 0.0532
52 Week Range
0.0290 - 12.5800
Average volume
92.9K
Short Interest
66.77K (10/13/23)
% of Float Shorted
0.57%
Market Cap
$629.98K
Revenue
N/A
Net Income
-$19.83M
2020 Sales Growth
N/A
Rev. per Employee
$313.33K
P/E Ratio
N/A
EPS
-$0.8310
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman
Naseem Amin MD, MBA
Independent Director
Scott P Bruder MD, PhD
Independent Director
Mary Ann Cloyd CPA
SEC filings
DateFormEvent
6 Mar, 2024 15-12G
4 Mar, 2024 8-K
1 Mar, 2024 SCHEDULE 1
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
12 Feb, 2024 DEFA14A
12 Feb, 2024 DEFA14A
30 Jan, 2024 8-K
26 Jan, 2024 SC 13G
26 Jan, 2024 SCHEDULE 1
22 Jan, 2024 8-K
10 Jan, 2024 8-K
3 Jan, 2024 DEFA14A
27 Dec, 2023 25-NSE
12 Dec, 2023 8-K
21 Nov, 2023 8-K CEO Change
14 Nov, 2023 10-Q
6 Nov, 2023 DEF 14A
27 Oct, 2023 PRE 14A
18 Oct, 2023 SC 13D/A
17 Oct, 2023 SC 13D/A
16 Oct, 2023 S-8 POS
16 Oct, 2023 S-8 POS
16 Oct, 2023 S-8 POS
16 Oct, 2023 S-8 POS
16 Oct, 2023 S-8 POS
16 Oct, 2023 S-8 POS
16 Oct, 2023 S-8 POS
16 Oct, 2023 S-8 POS
16 Oct, 2023 RW
16 Oct, 2023 4
13 Oct, 2023 8-K
13 Oct, 2023 8-K
14 Aug, 2023 10-Q
7 Aug, 2023 8-K
24 Jul, 2023 8-K
20 Jul, 2023 8-K
29 Jun, 2023 8-K
9 Jun, 2023 4
9 Jun, 2023 4
9 Jun, 2023 4
9 Jun, 2023 4
9 Jun, 2023 SC 13G/A
9 Jun, 2023 4
9 Jun, 2023 4
9 Jun, 2023 4
9 Jun, 2023 EFFECT
9 Jun, 2023 4
9 Jun, 2023 4
9 Jun, 2023 8-K
8 Jun, 2023 CORRESP
8 Jun, 2023 SC 13D/A
7 Jun, 2023 UPLOAD
7 Jun, 2023 S-8
7 Jun, 2023 4
7 Jun, 2023 144
5 Jun, 2023 8-K
2 Jun, 2023 S-3
31 May, 2023 424B5
26 May, 2023 SC 13G/A
25 May, 2023 SC 13G
22 May, 2023 4
22 May, 2023 SC 13D/A
19 May, 2023 4
18 May, 2023 144
15 May, 2023 10-Q
15 May, 2023 8-K
11 May, 2023 8-K
11 May, 2023 8-K CEO Change
5 May, 2023 8-K
28 Apr, 2023 DEF 14A
28 Apr, 2023 ARS
28 Apr, 2023 DEFA14A
25 Apr, 2023 8-K
3 Apr, 2023 3
31 Mar, 2023 10-K
31 Mar, 2023 8-K
17 Mar, 2023 SC 13G
14 Mar, 2023 SC 13G
6 Mar, 2023 8-K
6 Mar, 2023 424B5
3 Mar, 2023 8-K
14 Feb, 2023 4
14 Feb, 2023 4
14 Feb, 2023 4
14 Feb, 2023 4
14 Feb, 2023 4
14 Feb, 2023 4
14 Feb, 2023 4
14 Feb, 2023 4
14 Feb, 2023 4
9 Feb, 2023 8-K
19 Jan, 2023 424B5
18 Jan, 2023 8-K
5 Jan, 2023 8-K
13 Dec, 2022 4
13 Dec, 2022 4
13 Dec, 2022 4
13 Dec, 2022 4
14 Nov, 2022 10-Q
14 Nov, 2022 8-K
27 Sep, 2022 8-K
15 Aug, 2022 10-Q
15 Aug, 2022 8-K
7 Jun, 2022 8-K
11 May, 2022 8-K
11 May, 2022 10-Q
25 Apr, 2022 DEF 14A
25 Apr, 2022 DEFA14A
31 Mar, 2022 10-K
31 Mar, 2022 8-K
14 Feb, 2022 SC 13G/A
28 Jan, 2022 4
28 Jan, 2022 4
28 Jan, 2022 4
28 Jan, 2022 8-K
28 Jan, 2022 4
5 Jan, 2022 8-K
4 Jan, 2022 8-K/A
4 Jan, 2022 4
4 Jan, 2022 4
4 Jan, 2022 4
4 Jan, 2022 4
4 Jan, 2022 4
17 Dec, 2021 8-K
15 Nov, 2021 8-K
15 Nov, 2021 10-Q
12 Nov, 2021 8-K CEO Change
12 Oct, 2021 8-K CEO Change
8 Oct, 2021 3
6 Oct, 2021 8-K
31 Aug, 2021 8-K
5 Aug, 2021 10-Q
5 Aug, 2021 8-K
11 Jun, 2021 S-8
11 Jun, 2021 8-K/A
8 Jun, 2021 4
26 May, 2021 8-K
11 May, 2021 10-Q
11 May, 2021 8-K
28 Apr, 2021 SC 13D/A
26 Apr, 2021 4
13 Apr, 2021 DEFA14A
13 Apr, 2021 DEF 14A
2 Apr, 2021 4
31 Mar, 2021 8-K
22 Mar, 2021 4
11 Mar, 2021 10-K
11 Mar, 2021 8-K
12 Feb, 2021 SC 13G/A
11 Jan, 2021 8-K
5 Jan, 2021 SC 13G/A
Last update:2024-03-06 13:17:16.267048
Bellerophon Therapeutics, Inc. by TradingView

Sign Up to Subscribe